These alterations modulate several immune components, including the infiltration and the exhaustion status of the CD8 T cells in addition to the expression of the chemokine CCL4 and the chemokine receptor CCR6 to finally potentiate the tumor growth. The gene discussed is CCL4; the disease is neoplasm.